Feedback / Questions
EP-201 - EpiThany, Aston Sci.
https://www.prnewswire.com/news-releases/us-fda-approves-aston-scis-phase-2-ind-for-ovarian-cancer-vaccine-ast-201-301924251.html
Sep 12, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next